As per the new schedule, the NEET-MDS Stray vacancy Round counselling for the students who qualified the UG medical entrance test will now commence on 26th July for the All India Quota/Deemed/Central ...

A recent randomized clinical trial has found that dalbavancin, a long-acting lipoglycopeptide antibiotic, does not provide superior outcomes compared with standard-of-care therapy in adults with ...

In a recent development, scientists from the US have demonstrated that Artificial Intelligence (AI) can detect early-stage laryngeal, or voice box, cancer by analyzing subtle changes in a patient’s ...

Regarding the above, the Drugs Controller General of India has written to all zonal and subzonal offices of CDSCO, directing them not to accept any physical applications for WHO-GMP Certificates of ...

Get Latest News, Breaking News about madras high court. Stay connected to all updated on madras high court ...

Get Latest News, Breaking News about Metformin. Stay connected to all updated on Metformin ...

10 Acting as independent appraisers during various examinations to ensure fairness and quality. Therefore, through the notice, it has been informed that the NBEMS has launched a Faculty Empanelment ...

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight, food intake and many measures of appetite more than placebo and ...

Mumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Applications (ANDAs) for Liraglutide Injection ...

Kolkata: The National Medical Commission (NMC) reduced altogether 30 MD/MS seats in seven state-run medical colleges in 2023 and 2024 in West Bengal. The list of medical colleges that were penalised ...

Kannur: In an unfortunate incident, Dr A.K. Rairu Gopal, fondly known as 'Two-rupee doctor'- for his decades-long dedication to treating thousands of poor patients at a nominal fee, passed away at the ...

Paris: Sanofi announces the completion of its acquisition of Vigil Neuroscience, Inc. This acquisition strengthens Sanofi's early-stage pipeline in neurology with VG-3927, a novel, oral, ...